Unveiling the hidden regulators: how post-translational modifications influence the progression and treatment of hepatocellular carcinoma. [PDF]
Qi S +7 more
europepmc +1 more source
Identification of immune-related targets of N6-methyladenosine regulators in hepatocellular carcinoma via RNA-seq analysis. [PDF]
Zhao Y, Zhang D, Zheng H, Chen X, Xu L.
europepmc +1 more source
Physical Activity and Hepatocellular Carcinoma Outcomes: a Narrative Review of Pre-clinical, Observational, and Interventional Evidence. [PDF]
Kim N +4 more
europepmc +1 more source
RBM15B promotes hepatocellular carcinoma progression via IGF2BP1-mediated ITSN2 mRNA stabilization. [PDF]
Xu Y +8 more
europepmc +1 more source
Combining tissue-derived microRNAs with clinical risk models for prediction of HCC recurrence after liver transplantation: A proof-of-concept study. [PDF]
Lederer T +14 more
europepmc +1 more source
Therapeutic Potential of Silver Nanoparticles in Hepatocellular Carcinoma: From Pathogenesis to Clinical Perspectives. [PDF]
Alawi MMK +5 more
europepmc +1 more source
Repurposed Acarbose Targets Nidogen-1 to Remodel the Tumor Stroma and Suppress Portal Vein Tumor Thrombus in Hepatocellular Carcinoma. [PDF]
Han T +25 more
europepmc +1 more source
Thrombomodulin Mitigates the Progression of Hepatocellular Carcinoma in Steatotic Liver. [PDF]
Yamaguchi M +6 more
europepmc +1 more source
Gd-EOB-DTPA MRI radiomics-clinical nomogram for preoperatively predicting dual-positive Ki-67/MVI status in hepatocellular carcinoma: A retrospective study. [PDF]
Yu H, Kong D, Mo X, Wu J, Wu J, Wang P.
europepmc +1 more source

